SYFae4c71faaebd4f44ae2af1cdeaac9e93Registry ID: 2025-521047-20-00|SuspendedPhase 4
Loading search results
interventional
N/A
1 country
1
To determine whether opioid-free general anesthesia, compared to opioid-based general anesthesia, reduces the frequency and intensity of postoperative nausea and vomiting in patients undergoing robotic bariatric surgery
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 14, 2025
Actual (reported)Visual Analog Scale for Nausea (VAS-N)
Visual Analog Scale for Pain (VAS-P)
Opioid demand during the 24 hours following surgery
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
LIDOCAINE HYDROCHLORIDE
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INFUSION
View registry recordFormulated product
Dexdor 100 micrograms/ml concentrate for solution for infusion
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INFUSION
View registry recordFormulated product
KETOLAR 50 mg/ml solución inyectable.
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INJECTION
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
LIDOCAINE HYDROCHLORIDE
Named ingredient: Lidocaine hydrochloride
View registry recordDexdor 100 micrograms/ml concentrate for solution for infusion
Named ingredient: Dexmedetomidine
View registry recordKETOLAR 50 mg/ml solución inyectable.
Named ingredient: Ketamine hydrochloride
View registry recordHospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida
Lleida, 25196, Spain
Diego Arango Del Corro
First Submitted
April 14, 2025
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Anesthesia for Obese Patients: Desflurane Versus Xenon
Contact the study team to confirm eligibility.